On 22nd January 2026, ERA4TB partners from @nicecomms.bsky.social and Consiglio Nazionale delle Ricerche hosted a webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587".
The recording is now available to view via the ERA4TB website: era4tb.org/video-library/.
📣 ERA4TB webinar alert
We are three days away from our joint webinar on "Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587".
To find out more information and to register, please click on the link below: lnkd.in/eR9CXsCJ.
📣 ERA4TB webinar alert!
Modelling the Future: Early-Phase Development and HTA Insights from TBAJ-587 (via Zoom)
Thursday 22nd January 2026, 1 pm - 2 pm (UK) | 2 pm - 3 pm (CET)
To register for this event, please sign up via this link: lnkd.in/eWaj-4Bi
As we come to the end of 2025, ERA4TB would like to take this opportunity to wish all our partners, collaborators and followers a wonderful holiday season.
We look forward to continuing our mission of developing new treatment regimens for Tuberculosis in 2026!
In this latest study under @era4tb.bsky.social, researchers adopted physiologically‑based pharmacokinetic (PBPK) modelling and used a detailed computational model to project what those concentrations likely are in human lungs (both healthy and TB-infected).
👉 Read at: https://bit.ly/3KA2RQx
ERA4TB decided to share some of our personal highlights for 2025!
To read our full year in review post, please click on the following link: lnkd.in/eEUJsw7b
Colleagues from @unizar.es and Università di Pavia also met up with Natalya Serbina from @tballiance.bsky.social Alliance and Khisi Mdluli from The Gates Foundation.
Well done to our consortium members!
Giovanni Stelitano (also from, Università di Pavia) presented his own unmoderated e-poster session, on "Mycobacterium tuberculosis Tryptophan Synthase as a target for novel antitubercular drugs".
This week, we shall find out what else our consortium members got up to during the conference!
Università di Pavia's Deborah Recchia, hosted an unmoderated e-poster session on "Investigating the Impact of Inoculum Size on EUCAST Methodology for MIC Mycobacterium tuberculosis determinations".
A thread 🧵
We have more updates from ERA4TB consortium members who attended The Union World Conference on Lung Health 2025.
Last week, we heard from our Universidad de Zaragoza colleagues Lara Muñoz-Muñoz, Jordana Galizia, and Marie Sylvianne Radoarivelo who each hosted e-poster sessions.
Well done to Jordana, Marie Sylvianne and Lara!
If you are interested in learning more about the above three e-poster presentations; please feel free to contact the mentioned colleagues.
We will providing more updates from ERA4TB in the coming days!
Lara Muñoz-Muñoz (UNIZAR) presented an e-poster presentation on "The impact of phylogenetic lineage on the drug susceptibility of Mycobacterium tuberculosis".
Marie Sylvianne Rabodoarivelo presented an e-poster presentation on "In vitro characterization of GSK2556286 activity in combination with Bedaquiline and Pretomanid against M. tuberculosis"
Jordana Galizia, PhD (UNIZAR), presented an e-poster presentation on "Assessing the translational value of in vitro time-kill assays in TB drug regimens development".
A thread 🧵
ERA4TB consortium members from Università di Pavia, @unizar.es and the @tballiance.bsky.social Alliance attended The Union World Conference on Lung Health (2025) in Copenhagen, Denmark.
Three of our colleagues, from @unizar.es, hosted e-poster presentations for conference attendees.
Fernando Sanz García, from @unizar.es, presented a poster on “An assay toolkit for anti-tuberculosis drugs in the hollow-fiber system”.
The poster informed readers, how key optimization tests that the hollow-fibre system, should require to allow reproducibility and robustness in its results.
From the 6th October 2025 to 7th October 2025, ERA4TB consortium members from @unizar.es, @uc3m.es and @pasteurlille.bsky.social attended MYCOVLC 2025. This annual gathering of Mycobacteria-focused laboratories, based in Spain, took place at CaixaForum in Valencia.
Our latest research under @era4tb.bsky.social, highlights that small adjustments in the hollow fiber assays better reflects how TB drugs really perform.
Learn more through a webinar on 21 October 2025.
👉 Research paper: https://bit.ly/4q7jIKE
👉 Webinar registration: https://bit.ly/3VN3Sa5
📣 ERA4TB webinar alert!
🕒 Only one day left!
ERA4TB, in collaboration with @NICEComms and the @WHO, are proud to introduce our speakers for tomorrow's webinar!
Register to save your spot: tinyurl.com/ERA4TB
📣 ERA4TB webinar alert!
🕒 Only two days left! Do not miss our online webinar, focusing on tackling anti-microbial resistance through policy and partnerships
Register here: tinyurl.com/ERA4TB
The team presented to general audience members, the #HollowFibreSystem. They explained how this innovative piece of technology, is supporting research in drug development.
Well done to those involved!
On Friday 26th September 2025, #ERA4TB Consortium members from @unizar.es and Università di Padova participated at the European Researchers' Night (2025) celebrations in Zaragoza, Spain.
📣 ERA4TB Webinar Announcement!
One week left to register for our webinar on 'Innovating Access: Tackling Anti-Microbial Resistance Through Policy'.
📅 Date: 8 October 2025; 1-2pm UK time
💻 Register here: tinyurl.com/ERA4TB
After a fun round of memory games, contestants were awarded with stickers, featuring the ERA4TB logo.
Well done Deborah Recchia, Maria Rosalia Pasca and the rest of our colleagues on creating such a fun and interactive experience!
The team created a poster, featuring Alessandro Stamilla in cartoon form. Using terminology tailored for a younger audience, the poster explained what the ERA4TB project is and its goal for defeating Tuberculosis (TB).
Some exciting news!
#ERA4TB Consortium Members from University of Pavia, hosted an interactive stand at Sharper Night - European Researchers' Night (2025).
ERA4TB Webinar 📣
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍✨
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from NICE & WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @amr-accelerator.bsky.social @tballiance.bsky.social
The other poster looked at Investigating Bedaquiline Mechanisms of Action and Resistance: A Focus on MmpL4/MmpL5 Siderophore Transporters and the Novel Diarylquinoline TBAJ-587
If you would like to know more about Deborah’s work with EUCAST or TBAJ-587, please reach out to us.
ERA4TB Webinar 📣
How can health systems respond to #AMR through innovation & evidence-based policy? 🌍
Join our ERA4TB webinar
🗓️ 8 Oct 2025 | 1–2pm UK | 2–3pm CEST
🎙️ Speakers from @NICEComms & @WHO
👉 Register: tinyurl.com/ERA4TB
@amr-accelerator.bsky.social @who.int @nicecomms.bsky.social
More #ERA4TB partners SIMGM Congress - Microbiology 2025!
Deborah Recchia (University of Pavia) showcased two of her posters at SIMGM Congress.
The first poster, focused on the optimization of European Committee on Antimicrobial Susceptibility Testing (EUCAST).
